INNOVATE Corp. announced a 12.5% revenue increase to $1.25 billion in 2025, led by its Infrastructure segment's strong project backlog now at $1.8 billion. Despite this growth, the company reported a net loss of $64 million for the year, mainly due to higher interest expenses and losses in Life Sciences and Spectrum segments. Key highlights include FDA approval for MediBeacon's new system and a major 600-system commitment in China for R2. The company expects improved performance in 2026, especially in Spectrum, supported by favorable FCC rulings and new network launches.
Purecore Metals Inc. has signed a non-binding letter of intent with Skyharbour Resources to acquire an option to earn up to 100% interest in the Yurchison uranium property in Saskatchewan's Athabasca Basin. The property covers over 35,000 hectares an...
Shirofune has introduced Walmart Connect, an integration that allows advertisers and agencies to manage Walmart retail media campaigns alongside other digital channels within a single platform. This automation reduces manual bid adjustments and repor...
Point completed a $508.6 million rated asset-backed securitization of its Home Equity Investment (HEI) assets, marking the largest transaction ever in the HEI asset class. The deal attracted over 30 institutional investors and priced at significantly...
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
Red Light Holland, after acquiring Filament Health, has expanded its capabilities in pharmaceutical-grade psilocybin development. Filament completed a shipment of its botanical psilocybin drug candidate, PEX010, to the European Union to support multi...
